Jonathan S. Schulman
- Denver
- New York
Notice
Before proceeding, please note: If you are not a current client of Perkins Coie, please do not include any information in this e-mail that you or someone else considers to be of a confidential or secret nature. Perkins Coie has no duty to keep confidential any of the information you provide. Neither the transmission nor receipt of your information is considered a request for legal advice, securing or retaining a lawyer. An attorney-client relationship with Perkins Coie or any lawyer at Perkins Coie is not established until and unless Perkins Coie agrees to such a relationship as memorialized in a separate writing.
Jonathan advises public companies on , SEC disclosure obligations, corporate governance matters, and capital markets transactions.
Jonathan Schulman advises public companies on SEC reporting, compliance and disclosure issues, stock exchange rules, proxy advisory firm guidelines, stockholder activism, and general corporate matters.
Jonathan also represents public companies and underwriters in a variety of capital markets transactions, including initial public offerings, underwritten equity and debt offerings, Rule 144A debt offerings, convertible note offerings, commercial paper programs, and private placements. He also counsels public companies in a variety of M&A transactions.
Education & Credentials
Education
- University of Virginia School of Law, J.D., Editorial Board, Virginia Law & Business Review, 2014
- University of Miami, B.B.A., Entrepreneurship, summa cum laude, 2010
Bar and Court Admissions
-
Colorado
-
New York
Related Employment
- Latham & Watkins LLP, New York, NY and Washington, D.C., Associate, 2014-2018
- Latham & Watkins LLP, New York, NY, Summer Associate, 2013
Professional Recognition
Recognized by Best Lawyers: Ones to Watch for Corporate Law, 2024-2026
Professional Experience
Public Company Representation
Jonathan provides ongoing public company representation to a number of public companies, including:
- Crocs, Inc.
- Everus Construction Group, Inc.
- Knife River Corporation
- MDU Resources Group, Inc.
- Molson Coors Beverage Company
- Pacira BioSciences, Inc.
Capital Markets & Corporate Finance
Amcor in over $5.5 billion of senior notes offerings
Amcor in its multibillion-dollar commercial paper programs
Crocs in $700 million of Rule 144A senior notes offerings
Crocs in a $244 million block trade of its common stock
MDU in its approximately $230 million follow-on offering of common stock with an equity forward
MDU in its up to $400 million ATM program with an equity forward
Pacira BioSciences in a $287.5 million Rule 144A offering of convertible senior notes
CAI International in multiple preferred stock and ATM offerings
Gevo in multiple follow-on common stock, warrant, and ATM offerings
Ideal Power in multiple follow-on offerings
The underwriters in multiple follow-on offerings of Fate Therapeutics
Representation of other various issuers and underwriters in connection with initial public offerings (IPOs), underwritten public offerings, at-the-market (ATM) offerings, private investment in public equity (PIPEs), private placements and other financing transactions
Mergers & Acquisitions
Crocs (Nasdaq: CROX) in its $2.5 billion acquisition of HEYDUDE
RadNet, Inc. (Nasdaq: RDNT) in its acquisition of iCAD, Inc. (Nadsaq: iCAD)
Pacira BioSciences (Nasdaq: PCRX) in its acquisition of Flexion Therapeutics (Nasdaq: FLXN)
Pacira BioSciences (Nasdaq: PCRX) in its acquisition of MyoScience
CAI International (NYSE: CAI) in its acquisition by Mitsubishi HC Capital
SMTC Corporation (Nasdaq: SMTX) in its acquisition by H.I.G. Capital
AeroGrow (OTC: AERO) in its acquisition by Scotts Miracle-Gro (NYSE: SMG)
Peak Resorts (Nasdaq: SKIS) in its acquisition by Vail Resorts (NYSE: MTN)
